NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference

Brain Res Bull. 2005 Jan 30;64(6):493-503. doi: 10.1016/j.brainresbull.2004.10.005.

Abstract

The effects of dopaminergic and glutamatergic antagonists on the drug-induced reinstatement of a previously extinguished morphine conditioned place preference (CPP) in mice were evaluated. Following extinction of a place preference induced by morphine (40 mg/kg), a non-contingent injection of the dopaminergic antagonists SCH 23390 (0.125, 0.5 mg/kg), raclopride (0.3, 1.2 mg/kg), haloperidol (0.1, 0.2 mg/kg) and the dopamine (DA) release inhibitor CGS 10746B (1, 10 mg/kg) or glutamatergic NMDA antagonists memantine (10, 20, 40 mg/kg) and MK-801 (0.1, 0.2, 0.3 mg/kg) alone or with 10 mg/kg morphine was given. Neither the dopaminergic nor the glutamatergic antagonists alone reinstated the place preference. Dopamine antagonists failed to block the morphine-induced reinstatement of place preference while memantine and MK-801 blocked it with intermediate and high doses. These results suggest that drug-induced reinstatement of place preference may be largely independent of dopamine and more closely related to glutamatergic neurotransmission.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Analysis of Variance
  • Animals
  • Behavior, Animal / drug effects
  • Conditioning, Operant / drug effects*
  • Dopamine Antagonists / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Extinction, Psychological / drug effects
  • Male
  • Mice
  • Mice, Inbred Strains
  • Morphine / pharmacology*
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*

Substances

  • Analgesics, Opioid
  • Dopamine Antagonists
  • Excitatory Amino Acid Antagonists
  • Receptors, N-Methyl-D-Aspartate
  • Morphine